Kanai Takanori, Nemoto Yasuhiro, Tomita Takayuki, Totsuka Teruji, Watanabe Mamoru, Hibi Toshifumi
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Inflamm Bowel Dis. 2009 Jun;15(6):926-34. doi: 10.1002/ibd.20738.
Despite the advent of an age when "malignant" leukemia is cured by bone marrow transplantation, "benign" inflammatory bowel diseases (IBDs) are still intractable lifelong diseases. Why is it that once an IBD develops it lasts a long time? We propose that, the same as in the response to vaccination, immune memory T cells that remember the disease are formed in IBDs and, perceiving them as "benign T-cell leukemia"-like lifelong pathology that hematogenously spreads throughout the body, we here propose that the bone marrow itself, which produces large amounts of the survival factor IL-7, is the reservoir for colitogenic CD4(+) memory T cells responsible for the intractability of IBDs.
尽管如今“恶性”白血病可通过骨髓移植治愈,但“良性”炎症性肠病(IBD)仍是难以治愈的终身疾病。为何IBD一旦发病就会持续很长时间?我们提出,与对疫苗接种的反应相同,IBD中会形成记忆疾病的免疫记忆T细胞,并且将它们视为像“良性T细胞白血病”一样通过血液在全身扩散的终身病理状态,我们在此提出,产生大量生存因子IL-7的骨髓本身,是导致IBD难以治愈的致结肠炎CD4(+)记忆T细胞的储存库。